Apremilast for the treatment of psoriasis

MS Chimenti, T Gramiccia, R Saraceno… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Psoriasis is a chronic inflammatory skin disease characterized by dysregulation
of the immune system and release of pro-inflammatory mediators. Drugs available for …
被引用次数：30 相关文章

Apremilast for the treatment of psoriasis

MS Chimenti, T Gramiccia… - Expert opinion on …, 2015 - pubmed.ncbi.nlm.nih.gov
Introduction Psoriasis is a chronic inflammatory skin disease characterized by dysregulation
of the immune system and release of pro-inflammatory mediators. Drugs available for …

Apremilast for the treatment of psoriasis

MS Chimenti, T Gramiccia, R Saraceno… - EXPERT OPINION …, 2015 - publicatt.unicatt.it
Introduction: Psoriasis is a chronic inflammatory skin disease characterized by dysregulation
of the immune system and release of pro-inflammatory mediators. Drugs available for …

Apremilast for the treatment of psoriasis.

M Chimenti, T Gramiccia, R Saraceno… - EXPERT OPINION …, 2015 - art.torvergata.it
Introduction: Psoriasis is a chronic inflammatory skin disease characterized by dysregulation
of the immune system and release of pro-inflammatory mediators. Drugs available for …

Apremilast for the treatment of psoriasis.

MS Chimenti, T Gramiccia, R Saraceno… - Expert Opinion on …, 2015 - europepmc.org
Psoriasis is a chronic inflammatory skin disease characterized by dysregulation of the
immune system and release of pro-inflammatory mediators. Drugs available for psoriasis …

Apremilast for the treatment of psoriasis

MS Chimenti, T Gramiccia, R Saraceno… - EXPERT OPINION ON …, 2015 - arpi.unipi.it
Psoriasis is a chronic inflammatory skin disease characterized by dysregulation of the
immune system and release of pro-inflammatory mediators. Drugs available for psoriasis …